Paragon Capital Management (Kansas)’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Paragon Capital Management (Kansas)’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200	Closed	-$34K	–	344
2019 Q1	$34K	Buy	+200	New	+$29.8K	0.02%	106

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Paragon Capital Management (Kansas)'s GWPH Position: Q2 2019 in Review

Paragon Capital Management (Kansas) sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2019, closing a stake of 200 shares — an estimated $34K sold.

Paragon Capital Management (Kansas) first reported a position in GWPH in Q1 2019 and held it in 1 quarter. The position peaked at $34K in Q1 2019. 318 funds tracked by Wall St. Rank hold GWPH as of Q2 2019.

Paragon Capital Management (Kansas) reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2019 after selling out during the quarter.
Paragon Capital Management (Kansas) sold 200 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2019, an estimated $34K.
Paragon Capital Management (Kansas) first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 1 quarter.
Paragon Capital Management (Kansas)'s GW Pharmaceuticals Plc American Depositary Shares position peaked at $34K in Q1 2019.
318 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2019.

Based on Paragon Capital Management (Kansas)'s 13F filing for Q2 2019, filed 6 Aug 2019.